Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Sernova Corp (SEOVF)

Sernova Corp (SEOVF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Sernova Corp 700 COLLIP CIRCLE SUITE 114 LONDON A6 N6G 4X8 CAN

www.sernova.com P: 877-299-4603

Description:

Sernova Corp. is a regenerative medicine company. It is engaged in developing medical technologies for the treatment of chronic debilitating metabolic diseases such as diabetes, blood disorders including hemophilia and other diseases treated through replacement of proteins or hormones missing or in short supply within the body. The company's implantable medical device for therapeutic cells consists of Cell Pouch(TM). Sernova Corp. is headquartered in London, Canada.

Key Statistics

Overview:

Market Capitalization, $K 101,642
Enterprise Value, $K 98,712
Shares Outstanding, K 303,408
Annual Sales, $ 0 K
Annual Net Income, $ -28,910 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -7,210 K
EBIT, $ -14,930 K
EBITDA, $ -18,890 K
60-Month Beta 1.16
% of Institutional Shareholders 0.00%
Float, K 303,408
% Float 100.00%
Short Volume Ratio 0.08

Growth:

1-Year Return -45.11%
3-Year Return -71.50%
5-Year Return 93.35%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth -400.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.02 on 03/18/24
Latest Earnings Date 03/21/24
Earnings Per Share ttm -0.09
EPS Growth vs. Prev Qtr 33.33%
EPS Growth vs. Prev Year 0.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

SEOVF Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -226.64%
Return-on-Assets % -145.26%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 5.83
Book Value/Share 0.06
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar